Exogenous Cushing Syndrome Mimicking Human Immunodeficiency Virus Lipodystrophy
Author(s) -
Samir K. Gupta,
Michael P. Dubé
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/342562
Subject(s) - lipodystrophy , ritonavir , medicine , fluticasone , protease inhibitor (pharmacology) , cushing syndrome , saquinavir , human immunodeficiency virus (hiv) , virology , immunology , corticosteroid , viral load , antiretroviral therapy
A 45-year-old man infected with human immunodeficiency virus (HIV) developed abnormal fat accumulations that initially were believed to be caused by HIV lipodystrophy. Further clinical evaluation revealed, however, that the patient had developed exogenous Cushing syndrome, which presumably was caused by the inhibition of CYP3A4's metabolism of inhaled fluticasone by the protease inhibitor ritonavir. Clinicians should be aware that clinical clues may indicate conditions other than lipodystrophy that may cause abnormal fat accumulation and that fluticasone should be cautiously administered to patients who are receiving ritonavir.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom